Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.

Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.

Pseudomonas aeruginosa can establish life-long airways chronic infection in patients with cystic fibrosis (CF) with pathogenic variants distinguished from initially acquired strain. Here, we analysed chemical and biological activity of P. aeruginosa Pathogen-Associated Molecular Patterns (PAMPs) in...

Full description

Bibliographic Details
Main Authors: Cristina Cigana, Laura Curcurù, Maria Rosaria Leone, Teresa Ieranò, Nicola Ivan Lorè, Irene Bianconi, Alba Silipo, Flora Cozzolino, Rosa Lanzetta, Antonio Molinaro, Maria Lina Bernardini, Alessandra Bragonzi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-12-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2793027?pdf=render

Internet

http://europepmc.org/articles/PMC2793027?pdf=render

Similar Items